Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)

Clinical trial NCT02203773 · TERMINATED

Trial details

NCT number: NCT02203773
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Myelogenous Leukemia Treatment Naive AML

Start date: 2014-10-06
Primary completion: 2022-06-16
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.